Recently fed, lots of free
energy sources. Precursors
anabolised (glucose to
glycogen, fatty acids to
triglycerides) for energy
stores
High levels of insulin allows
the cells to use glucose
from the blood as an
energy source, promoting
the storage of glucose as
glycogen
Post-absorptive
state
Between meals, reduced
free energy sources.
Storage molecules
catabolised into
precursors for energy
sources for cells
Insulin levels have fallen,
signalling the catabolism
of stored energy sources.
Insulin is important in
this process and it is
released in three
phases
Cephalic
Anticipation, smell and taste of
food activates the neural
pathway to the β cells of the
pancreas. Insulin then signals
the decrease in catabolism of
stored energy sources,
preparing the body for food
Gastro-intestinal
When food enters the GI
tract, hormones are
released, releasing more
insulin
Substrate
Absorbed nutrients
induce more insulin
release, so levels
remain high after
feeding
Plasma
Osmolality
An increase in the plasma
concentrate of
electrolytes such as Na+
and Cl- inhibits feeding, as
well as increasing thirst
Feeding is reduced when water is
withheld (dehydration anorexia) or
is accompanied with a hypertonic
fluid.
Effect is mediated
by osmoreceptors
in the brainstem
Satiety
Signals
Physical and chemical
signals affecting the
regulation of short and
long term feeding
behaviour
Gastric
distension
Activation of
stretch receptors
after feeding as
stomach volume
increases
Signals the
sensation of
feeling full
Decreases feeding,
although this
reflex can be
overidden
Cholecystokinin
(CKK)
Secreted into
the stomach
to aid
digestion and
absorption
Binds to receptors
on the vagus nerve,
aiding the
inhibitory effects of
gastric distension
on appetite
Can be blocked by
receptor antagonists and
lesions to the nucleus of
solitary tract (NTS), which
is where the impulses are
received
Adiposity
Body fat levels
affect feeding
behaviour
Food deprivation with
weight loss leads to
increased feeding until
the level of adiposity is
restored
Forced feeding with
weight gain leads to
decreased feeding until
adiposity has returned
to normal levels
Parabionts
Two animals surgically
joined by skin or muscle
with the same circulation
but individual nervous
systems
Joining a lean and obese animal
causes the lean animal to lose
weight, suggesting that factors
released by the obese animal
cause a decreased food intake and
increased satiety in the lean
animal
Proof that fat deposits
communicate with the brain by
releasing chemical mediators into
the circulation
Leptin
Hormone
secreted into
the blood by
adipose tissue
Levels in the plasma
are directly
proportional to
adiposity
Negative feedback
for caloric
homeostasis
Mutations
Receptor
Hyperphagia
and obesity
Leptin
administration does
not cure as the
receptor is
inactivated
Ob-R, cytokine receptor
found in hypothalamus.
Carry out intracellular
signalling via the Jak/Stat
pathway
Gene
Hyperphagia
and obesity
Leptin
administration
cures
Mutations in the insulin
receptor gene increases
feeding and causes
obesity
Human obesity is
linked to leptin
and insulin
resistances
Dual Centre
Hypothesis
Ventromedial Nuclei
(VMN)
Satiety centre
Lesions induce
hyperphagia
and obesity
Also causes
autonomic
dysfunction,
increased insulin
resistance and eating
more often
New feeding set point is
established and eating stops
when the new increased weight
is reached
Lateral Hypothalamus
(LH)
Hunger
centre
Lesions induce
aphagia and
starvation
Also causes
adipsia,
akinesia and
sensory
neglect
Neuropeptides
Lateral Nucleus
(LH)
Appetite
stimulation
AgRP
Released from arcuate
nucleus, enhances appetite
by acting as an MC4
receptor antagonist,
blocking the effects of
α-MSH
Prevents a decrease in orexin A
release from the LH, as well as
preventing the increase of CRH
release in the PVN.
Long lasting
effects
NPY
Released from the arcuate
nucleus and enhances appetite
by acting on NPY receptors (Y1
and Y5) in the PVN and LH.
Increases
orexin A
release and
inhibits CRH
Strong, but short lived
effects
Paraventricular
Nucleus (PVN)
Appetite
suppression
α-MSH
Released from the
arcuate nucleus and
suppresses appetite
by inhibiting orexin
A (which increases
feeding) release
from the LH, and
increasing CRH
(which decreases
feeding) from the
PVN
Binds to
melanocortin
receptors
(MC4) in the
PVN and LH
Receptors important
as mutations in these,
as well as receptor
antagonists may cause
hyperphagia and
obesity
MC4 agonists are potential
therapeutic agents for
obesity
Arcuate nucleus regulates
indirectly, via the PVN and
LH. Its neuropeptides are
released into the nuclei,
affecting the release of
other neuropeptides.
Opposite effects on the
PVN and LH
When bound to its receptor in
the arcuate nucleus, leptin
has the opposite effects on
appetite suppressing and
enhancing neuropeptides. It
therefore decreases feeding
by directly and indirectly
affecting the release of
various neuropeptides in
many hypothalamic nuclei
Two main views on
how appetite is
regulated
Depletion - Repletion
Model
Feeding due to
decreased levels of
energy sources
(storage?)
Caloric Homeostasis
Model
Feeding due to decreased 'satiety
signals' produced from the last meal.
This would serve to maintain
constant levels of free and stored
energy sources